Postdiagnosis circulating osteoprotegerin and TRAIL concentrations and survival and recurrence after a breast cancer diagnosis: results from the MARIE patient cohort

Experimental studies suggest a role for osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in mammary tumor development and progression. These biomarkers have been minimally investigated with respect to outcomes in breast cancer patients.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Le Cornet, Charlotte (VerfasserIn) , Jung, Audrey Y. (VerfasserIn) , Johnson, Theron S. (VerfasserIn) , Behrens, Sabine (VerfasserIn) , Obi, Nadia (VerfasserIn) , Becher, Heiko (VerfasserIn) , Chang-Claude, Jenny (VerfasserIn) , Turzanski Fortner, Renée (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 April 2023
In: Breast cancer research
Year: 2023, Jahrgang: 25, Pages: 1-10
ISSN:1465-542X
DOI:10.1186/s13058-023-01625-4
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13058-023-01625-4
Volltext
Verfasserangaben:Charlotte Le Cornet, Audrey Y. Jung, Theron S. Johnson, Sabine Behrens, Nadia Obi, Heiko Becher, Jenny Chang-Claude and Renée T. Fortner
Beschreibung
Zusammenfassung:Experimental studies suggest a role for osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in mammary tumor development and progression. These biomarkers have been minimally investigated with respect to outcomes in breast cancer patients.
Beschreibung:Gesehen am 19.05.2023
Beschreibung:Online Resource
ISSN:1465-542X
DOI:10.1186/s13058-023-01625-4